CDCA8 and hepatocellular carcinoma: Furthermore, the identified biomarker <i>CDCA8</i> represents a promising therapeutic target warranting further investigation.<h4>Conclusion</h4>These discoveries provide novel evidence on senescence in HCC, which may tailor the pharmacological interventions to improve the clinical management.